Kissei Pharmaceutical Co., Ltd. (KSPHF)

Kissei Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,223	1,099	1,033	916	970	1,022
Market Cap Growth	29.36%	6.38%	12.77%	-5.58%	-5.02%	-15.39%
Enterprise Value	907	818	764	580	645	624
Last Close Price	30.28	23.85	22.88	18.81	21.10	22.20
PE Ratio	14.26	13.76	14.00	11.57	9.12	21.38
PS Ratio	1.97	1.86	2.07	1.81	1.80	1.64
PB Ratio	0.85	0.78	0.71	0.63	0.58	0.51
P/TBV Ratio	0.86	0.80	0.72	0.63	0.59	0.52
P/FCF Ratio	-	81.72	-	-	2677.87	-
P/OCF Ratio	-	25.24	-	-	76.86	-
EV/Sales Ratio	1.49	1.39	1.53	1.14	1.20	1.00
EV/EBITDA Ratio	12.76	11.79	13.96	25.97	33.64	14.83
EV/EBIT Ratio	23.25	21.22	28.75	-	-	45.81
EV/FCF Ratio	-	60.83	-	-	1779.80	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.12	0.12	0.16	0.50	0.70	0.37
Debt / FCF Ratio	-	0.64	-	-	37.27	-
Asset Turnover	0.36	0.35	0.31	0.29	0.26	0.28
Inventory Turnover	1.76	1.73	1.56	1.68	1.75	2.17
Quick Ratio	4.22	4.68	4.17	4.79	4.01	3.70
Current Ratio	5.86	6.45	5.92	6.73	5.30	5.10
Return on Equity (ROE)	5.77%	5.55%	5.43%	5.36%	6.17%	2.60%
Return on Assets (ROA)	1.43%	1.43%	1.04%	-0.31%	-0.35%	0.38%
Return on Capital (ROIC)	1.66%	1.66%	1.20%	-0.36%	-0.41%	0.45%
Return on Capital Employed (ROCE)	2.50%	2.50%	1.70%	-	-	0.60%
Earnings Yield	7.01%	7.27%	7.14%	8.64%	10.97%	4.68%
FCF Yield	-	1.22%	-1.84%	-7.21%	0.04%	-3.07%
Dividend Yield	2.55%	2.80%	2.37%	3.20%	2.19%	2.20%
Payout Ratio	-	31.78%	33.35%	29.78%	19.63%	46.83%
Buyback Yield / Dilution	3.93%	3.62%	1.86%	-	1.18%	0.11%
Total Shareholder Return	6.48%	6.42%	4.23%	3.20%	3.37%	2.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.